Cargando…
Secukinumab on Refractory Lupus Nephritis
Lupus nephritis (LN) is the most frequent severe organ manifestation of systemic lupus erythematosus (SLE). About 30% of patients are refractory to treatment. The authors report a case of treatment of LN with interleukin-17-targeted therapy, demonstrating its possible benefit, after reports of T hel...
Autores principales: | Costa, Rita, Antunes, Paula, Salvador, Pedro, Oliveira, Pedro, Marinho, António |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439396/ https://www.ncbi.nlm.nih.gov/pubmed/34540426 http://dx.doi.org/10.7759/cureus.17198 |
Ejemplares similares
-
Terbinafine Induced Lupus Erythematosus With Progression to Lupus Nephritis
por: Hindosh, Naif, et al.
Publicado: (2022) -
An Uncommon Correlation of Rheumatoid Arthritis and Lupus Nephritis: A Case Report on the Unusual Progression of Lupus Nephritis
por: Lam, Lyna C, et al.
Publicado: (2022) -
Lupus-Mediated Kidney Damage: Lupus Nephritis or Collapsing Glomerulopathy?
por: De La Cruz, Angel, et al.
Publicado: (2021) -
Systemic Lupus Erythematosus in the Elderly That Debuts With an Organic Manifestation of Lupus Nephritis
por: Khan, Anosh, et al.
Publicado: (2022) -
Lupus Nephritis Associated With Renal Cell Carcinoma
por: Mehta, Vivek, et al.
Publicado: (2022)